Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-28

Clinical Trial Update: A Study of LY2624803 in Japanese Participants With Transient Insomnia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of LY2624803 in Japanese participants with transient insomnia has completed and results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LY2624803 (LY2624803)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Sleep Initiation and Maintenance Disorders | Phase 1 | Status: COMPLETED | Results posted: 2016-01-28